OA10109A - Pharmaceutical composition of 5ht1-like receptor agonists for rectal administration - Google Patents

Pharmaceutical composition of 5ht1-like receptor agonists for rectal administration Download PDF

Info

Publication number
OA10109A
OA10109A OA60578A OA60578A OA10109A OA 10109 A OA10109 A OA 10109A OA 60578 A OA60578 A OA 60578A OA 60578 A OA60578 A OA 60578A OA 10109 A OA10109 A OA 10109A
Authority
OA
OAPI
Prior art keywords
pharmaceutical composition
daims
methyl
pharmaceutically acceptable
active ingrédient
Prior art date
Application number
OA60578A
Other languages
English (en)
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of OA10109A publication Critical patent/OA10109A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
OA60578A 1992-05-07 1994-11-04 Pharmaceutical composition of 5ht1-like receptor agonists for rectal administration OA10109A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions

Publications (1)

Publication Number Publication Date
OA10109A true OA10109A (en) 1996-12-18

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60578A OA10109A (en) 1992-05-07 1994-11-04 Pharmaceutical composition of 5ht1-like receptor agonists for rectal administration

Country Status (33)

Country Link
US (1) US5705506A (es)
EP (1) EP0639072B1 (es)
JP (1) JPH07506570A (es)
KR (1) KR100253111B1 (es)
AT (1) ATE163850T1 (es)
AU (1) AU670083B2 (es)
BE (1) BE1007024A5 (es)
BG (1) BG62120B1 (es)
BR (1) BR1100108A (es)
CA (1) CA2135179C (es)
CH (1) CH685920A5 (es)
CY (1) CY2039B1 (es)
CZ (1) CZ283512B6 (es)
DE (1) DE69317418T2 (es)
ES (1) ES2113533T3 (es)
FR (1) FR2690847B1 (es)
GB (2) GB9209882D0 (es)
GR (1) GR3026584T3 (es)
HK (1) HK95697A (es)
HU (2) HU227338B1 (es)
IE (1) IE75203B1 (es)
IL (1) IL105468A (es)
IT (1) IT1261471B (es)
NO (1) NO306700B1 (es)
NZ (1) NZ252132A (es)
OA (1) OA10109A (es)
RO (1) RO112993B1 (es)
RU (1) RU2118527C1 (es)
SG (1) SG46649A1 (es)
TW (1) TW231970B (es)
UA (1) UA37206C2 (es)
WO (1) WO1993021916A1 (es)
ZA (1) ZA933178B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AU749623B2 (en) * 1998-03-26 2002-06-27 Astellas Pharma Inc. Sustained release preparations
AU3731400A (en) * 1999-03-05 2000-09-21 Trustees Of University Technology Corporation, The Methods and compositions useful in inhibiting apoptosis
AR056690A1 (es) * 2005-10-14 2007-10-17 Athersys Inc Derivados de indol como inhibidores de indol como inhibidores del receptor 3 de histamina para el tartamiento de trastornos del sueno y cognitivos obesidad y otros trastornos de snc
US8653066B2 (en) 2006-10-09 2014-02-18 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
EP2451274B1 (en) 2009-07-08 2017-10-04 Charleston Laboratories, Inc. Pharmaceutical compositions
CN103402514B (zh) 2010-10-15 2016-01-13 康特拉医药公司 用于治疗运动障碍的血清素受体激动剂组合物
MY169068A (en) 2012-04-18 2019-02-12 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
CN109689036B (zh) 2016-07-11 2026-06-19 康特拉医药股份有限公司 用于治疗早晨运动不能的脉冲药物输送系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
DK157995C (da) * 1980-08-12 1990-08-06 Glaxo Group Ltd Analogifremgangsmaade til fremstilling af indolderivater
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (es) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
US4785016A (en) * 1984-12-04 1988-11-15 Glaxo Group Limited Indole derivatives
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
PH24976A (en) * 1987-08-13 1990-12-26 Glaxo Group Ltd Indole derivatives
CZ288351B6 (en) * 1990-06-07 2001-05-16 Astrazeneca Ab Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof

Also Published As

Publication number Publication date
HU211638A9 (en) 1995-12-28
NZ252132A (en) 1996-09-25
IL105468A (en) 1998-09-24
NO306700B1 (no) 1999-12-13
EP0639072B1 (en) 1998-03-11
GB2266665A (en) 1993-11-10
KR100253111B1 (en) 2000-07-01
ATE163850T1 (de) 1998-03-15
IE930339A1 (en) 1993-11-17
NO944214D0 (no) 1994-11-04
HK95697A (en) 1997-08-08
BE1007024A5 (fr) 1995-02-21
BG62120B1 (bg) 1999-03-31
FR2690847A1 (fr) 1993-11-12
BG99167A (bg) 1995-06-30
RO112993B1 (ro) 1998-03-30
RU2118527C1 (ru) 1998-09-10
ZA933178B (en) 1994-01-10
IE75203B1 (en) 1997-08-27
AU670083B2 (en) 1996-07-04
HUT71418A (en) 1995-11-28
BR1100108A (pt) 1999-12-07
IT1261471B (it) 1996-05-23
ES2113533T3 (es) 1998-05-01
FR2690847B1 (fr) 1995-06-09
ITRM930286A0 (it) 1993-05-06
UA37206C2 (uk) 2001-05-15
JPH07506570A (ja) 1995-07-20
EP0639072A1 (en) 1995-02-22
CY2039B1 (en) 1998-04-30
GR3026584T3 (en) 1998-07-31
US5705506A (en) 1998-01-06
GB2266665B (en) 1996-05-22
AU4064093A (en) 1993-11-29
GB9309209D0 (en) 1993-06-16
DE69317418D1 (de) 1998-04-16
WO1993021916A1 (en) 1993-11-11
TW231970B (es) 1994-10-11
CA2135179A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
SG46649A1 (en) 1998-02-20
ITRM930286A1 (it) 1994-11-06
CH685920A5 (fr) 1995-11-15
GB9209882D0 (en) 1992-06-24
CZ283512B6 (cs) 1998-04-15
NO944214L (no) 1994-11-07
CA2135179C (en) 2000-12-05
DE69317418T2 (de) 1998-07-30
HU227338B1 (en) 2011-04-28
CZ272394A3 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
CA2135179C (en) Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration
JPH07196512A (ja) 医薬組成物
RU2146140C1 (ru) Средство для лечения нарушений сна и фармацевтическая композиция на его основе
CZ288834B6 (cs) Farmaceutický prostředek k ošetřování desynchronizačních poruch
IL155322A (en) Compositions of vehicles containing modafinil
AP544A (en) Compositions for rectal administration
EP0671908B1 (en) Pharmaceutical compositions comprising 5-ht 1? receptor agonists and absorption enhancers
JPH11507671A (ja) 良性前立腺過形成を処置するためのメラトニンアゴニスト
JPH01249720A (ja) 座薬